Andrew Blight, Chief Scientifc Officer at ACORDA THERAPEUTICS INC (ACOR), sold 9,481 shares at $23.08 ($219K) on 2012-10-22, disclosed to the SEC on 2012-10-24.
Scheduled sale ($219k) by Chief Scientifc Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ACOR | SELL | 2015-11-23 | $19K | — | Filing → |
| ACOR | SELL | 2015-10-21 | $1.0M | — | Filing → |
| ACOR | SELL | 2015-09-23 | $410K | — | Filing → |